相关实验视频
Updated: May 13, 2025

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
3.4K
希斯胺不耐受:一个被忽视的诊断,重复出现类似于过敏反应的症状
Takashi Nakamura1, Hirohisa Fujikawa1,2, Hirotake Ikeda1
1Department of Internal Medicine, Suwa Central Hospital, Nagano, JPN.
Cureus
|April 16, 2025
概括
基因组胺不耐受,基因组胺代谢的障碍,在吃海鲜后可以引起类似过敏反应的症状. 一个案例研究通过病史和皮肤刺痛测试证实了诊断,在饮食改变和抗组胺药物后症状消失.
科学领域:
- 临床医学 临床医学
- 过敏学 过敏学
- 胃肠病学 胃肠病学
背景情况:
- 基因组胺不耐受是一种由基因组胺代谢受损的特征.
- 它通常与患有类似过敏反应症状的个体有关,特别是在食用海鲜后.
- 海鲜可以在饮食中成为重要的基因组胺来源.
研究的目的:
- 介绍一个病例研究,该病例研究的患者有复发的类似过敏症的症状,这些症状归因于组胺素不耐受.
- 为了突出基因素不耐受症的诊断过程.
- 为了证明对胰岛素不耐受症的管理策略的有效性.
主要方法:
- 详细的患者病史,包括饮食摄入量.
- 基因组胺50皮肤刺伤测试用于诊断.
- 实施低组胺饮食.
- 预防性抗组胺药物. 预防性抗组胺药物.
主要成果:
- 一名26岁的男性患者在摄入海鲜后出现了反复出现的类似过敏反应的症状.
- 通过临床病史和皮肤刺痛测试,确诊了组胺素不耐受.
- 通过坚持低组胺饮食和服用抗组胺药物,可以预防症状复发.
结论:
- 在对类似过敏反应的差异诊断中,应考虑胰岛素不耐受性,特别是在食用海鲜后.
- 准确的诊断和适当的管理,包括饮食修改和药物治疗,可以显著改善患者的生活质量.
- 这一案例凸显了识别和管理基因素不耐受性的重要性.
相关概念视频
Allergic Reactions
27.2K
Overview
27.2K
Hypersensitivities
391
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
391
Allergic Drug Reactions
792
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
792
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
174
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
174
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K

